Harbor Capital Advisors, Inc. Haemonetics Corp Transaction History
Harbor Capital Advisors, Inc.
- $1.29 Billion
- Q3 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 42,859 shares of HAE stock, worth $2.14 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
42,859
Previous 28,633
49.68%
Holding current value
$2.14 Million
Previous $2.14 Million
2.2%
% of portfolio
0.16%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding HAE
# of Institutions
331Shares Held
53.3MCall Options Held
304KPut Options Held
77.8K-
Black Rock Inc. New York, NY5.96MShares$298 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$248 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.28MShares$214 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA2.15MShares$107 Million0.03% of portfolio
-
State Street Corp Boston, MA1.88MShares$94.2 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $2.57B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...